BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2587618)

  • 1. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A; Bucci FA; Del Val M; Cruz E
    Pharmacology; 1989; 39(1):59-68. PubMed ID: 2587618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A; Diecke FP; Mistry K; Ellison C; Cruz E
    Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A; Mistry K; Diecke FP; Cruz E
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myo-inositol transport in the lens of galactose-maintained rats.
    Beyer-Mears A; Diecke FP; Cruz E; Mistry K
    Curr Eye Res; 1992 Jan; 11(1):25-34. PubMed ID: 1559389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.
    Abdul Nasir NA; Agarwal R; Sheikh Abdul Kadir SH; Vasudevan S; Tripathy M; Iezhitsa I; Mohammad Daher A; Ibrahim MI; Mohd Ismail N
    PLoS One; 2017; 12(3):e0174542. PubMed ID: 28350848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol.
    Mackic JB; Ross-Cisneros FN; McComb JG; Bekhor I; Weiss MH; Kannan R; Zlokovic BV
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):804-10. PubMed ID: 8125742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts.
    Creighton MO; Ross WM; Stewart-DeHaan PJ; Sanwal M; Trevithick JR
    Exp Eye Res; 1985 Feb; 40(2):213-22. PubMed ID: 3979462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG; Stevens MJ
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J; Kim CS; Sohn E; Lee YM; Kim JS
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
    J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling cortical cataractogenesis: VI. Induction by glucose in vitro or in diabetic rats: prevention and reversal by glutathione.
    Ross WM; Creighton MO; Trevithick JR; Stewart-DeHaan PJ; Sanwal M
    Exp Eye Res; 1983 Dec; 37(6):559-73. PubMed ID: 6662206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.